The role of angiogenesis, inflammation and estrogen receptors in breast implant capsules development and remodeling.

Publication date: Available online 13 December 2017
Source:Journal of Plastic, Reconstructive & Aesthetic Surgery
Author(s): Francesco Segreto, Simone Carotti, Giovanni Francesco Marangi, Daniele Tosi, Maria Zingariello, Alfonso Luca Pendolino, Laura Sancillo, Sergio Morini, Paolo Persichetti
BackgroundCapsular contracture is the most common complication following breast implant placement. The multiple factors unbalancing the physiological response to the foreign body have not been fully elucidated. The aim of this study was to investigate the role of neo-angiogenesis, inflammation and estrogen receptors in peri-prosthetic tissue development and remodeling.MethodsThe study enrolled 31 women who underwent expander substitution with definitive implant. Specimens were stained with Hematoxylin/Eosin, Masson trichrome, immunohistochemistry and immunofluorescence for alpha-Smooth Muscle Actin, Estrogen Receptor-α (ER-α), Estrogen Receptor-β (ER-β), Collagen type I and III, CD31 (as a marker of neo-angiogenesis) and vascular endothelial growth factor (VEGF). Inflammatory infiltration was quantified and analyzed. Transmission electron microscopy was performed for ultrastructural evaluation.ResultsMyofibroblasts, mainly localized in the middle layer of capsular tissue, expressed VEGF, ER-α and ER-β. ER-β expression positively correlated with Collagen type I deposition (p=0.025). Neo-angiogenesis was predominant in the middle layer. CD31 expression positively correlated with Collagen type I expression (p=0.009) and inflammatory infiltration grade (p=0.004). The degree of inflammatory infiltration negatively correlated with the time from implantation (p=0.022)DiscussionThe middle layer is key in the development and remodeling of capsular tissue. Myofibroblasts produce VEGF, that induces neo-angiogenesis. New vessels formation is also correlated to the inflammatory response. Collagen deposition is associated with ER-β expression and neo-angiogenesis. These findings may prelude to targeted pharmacologic therapies able to control such interactions, thus hampering the self-sustaining loop promoting the progression of physiologic fibrosis towards pathologic contracture.